GB0701153D0 - Hydrophobic protein solubilisation composition - Google Patents

Hydrophobic protein solubilisation composition

Info

Publication number
GB0701153D0
GB0701153D0 GBGB0701153.9A GB0701153A GB0701153D0 GB 0701153 D0 GB0701153 D0 GB 0701153D0 GB 0701153 A GB0701153 A GB 0701153A GB 0701153 D0 GB0701153 D0 GB 0701153D0
Authority
GB
United Kingdom
Prior art keywords
composition
hydrophobic protein
protein solubilisation
solubilisation
hydrophobic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0701153.9A
Other versions
GB2434366A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BABRAHAM BIOSCIENCE TECHNOLOGI
Original Assignee
BABRAHAM BIOSCIENCE TECHNOLOGI
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BABRAHAM BIOSCIENCE TECHNOLOGI filed Critical BABRAHAM BIOSCIENCE TECHNOLOGI
Publication of GB0701153D0 publication Critical patent/GB0701153D0/en
Publication of GB2434366A publication Critical patent/GB2434366A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
GB0701153A 2006-01-21 2007-01-22 Composition for solubilisation of a hydrophobic protein Withdrawn GB2434366A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0601251.2A GB0601251D0 (en) 2006-01-21 2006-01-21 Protein solubilisation composition

Publications (2)

Publication Number Publication Date
GB0701153D0 true GB0701153D0 (en) 2007-02-28
GB2434366A GB2434366A (en) 2007-07-25

Family

ID=36010733

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0601251.2A Ceased GB0601251D0 (en) 2006-01-21 2006-01-21 Protein solubilisation composition
GB0701153A Withdrawn GB2434366A (en) 2006-01-21 2007-01-22 Composition for solubilisation of a hydrophobic protein

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0601251.2A Ceased GB0601251D0 (en) 2006-01-21 2006-01-21 Protein solubilisation composition

Country Status (2)

Country Link
GB (2) GB0601251D0 (en)
WO (1) WO2007083154A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007060599A1 (en) * 2007-12-15 2009-06-18 Merck Patent Gmbh Process for the extraction of membrane proteins
WO2011004158A1 (en) * 2009-07-08 2011-01-13 The University Of Birmingham Solubilisation of membrane proteins

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3367921D1 (en) * 1982-02-27 1987-01-15 Kuraray Co Neocarzinostatin complexes, a method for producing the same, and an antitumor agent containing said complexes as an active component
GB9717905D0 (en) * 1997-08-22 1997-10-29 Univ Aston Lipid-containing compositions and uses thereof
US6087452A (en) * 1998-06-02 2000-07-11 University Of Utah Metal-chelating surfacant
SE9904803D0 (en) * 1999-12-27 1999-12-27 Amersham Pharm Biotech Ab Method for the isolation of hydrophobic proteins
CA2606270A1 (en) * 2005-04-19 2006-10-26 Massachusetts Institute Of Technology Amphiphilic polymers and methods of use thereof
US20070026383A1 (en) * 2005-07-15 2007-02-01 Quintessence Biosciences, Inc. Methods and compositions for extracting membrane proteins

Also Published As

Publication number Publication date
GB2434366A (en) 2007-07-25
WO2007083154A1 (en) 2007-07-26
GB0601251D0 (en) 2006-03-01

Similar Documents

Publication Publication Date Title
EP1988922A4 (en) Protein formulations
EP2225275A4 (en) Protein formulation
ZA200810738B (en) Polypeptide
GB0620934D0 (en) Protein variants
GB0611116D0 (en) Proteins
PL1849352T3 (en) Combine
IL199547A (en) Preparation of romidepsin
EP2004674A4 (en) Antimicrobial protein
EP2116535A4 (en) Glucokinase-activating substance
IL198651A0 (en) COMPOSITION COMPRISING (-)-Ôêå9-TRANS-TETRAHYDROCANNABIONOL
GB0601976D0 (en) Proteins
GB0620735D0 (en) Proteins
IL193696A0 (en) Protein folding
GB2453901B (en) Protein solubilisation
EP2024516A4 (en) Perforin-2 proteins
GB0701153D0 (en) Hydrophobic protein solubilisation composition
GB0625671D0 (en) Protein formulation
GB2450822B (en) Sample preparation
GB0612443D0 (en) Protein
GB0620304D0 (en) Protein
GB0614682D0 (en) Proteins
GB0612623D0 (en) Proteins
GB0616969D0 (en) Protein
GB0613471D0 (en) Protein
GB0614683D0 (en) Protein

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)